single header image

Investors

Investors

Company News

Amarantus to Present at the 2nd Annual Marcum MicroCap Conference on May 30

Download PDF

SUNNYVALE, Calif., May 20, 2013 /PRNewswire/ -- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that Chief Executive Officer Gerald Commissiong will present at the 2nd Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at the Grand Hyatt Hotel in New York City.

The Company's presentation is scheduled to begin at 9:30 a.m. Eastern and will be available via a live webcast at http://wsw.com/webcast/marcum/ambs/.  An archived replay will be available for 90 days.

For more information, or to register for the conference, go to http://www.marcumllp.com/microcap

About Amarantus

Amarantus is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property and licenses for the diagnosis of Parkinson's disease and Alzheimer's disease. For further information please visit www.Amarantus.com.

About Marcum LLP

Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation. Ranked among the top 15, Marcum LLP offers the resources of 1,000 professionals, including over 125 partners, in more than 20 offices throughoutNew York, New Jersey, Massachusetts, Connecticut, Pennsylvania, California, Florida, Grand Cayman and China. Headquartered in New York City, the Firm's presence runs deep with full-service offices strategically located in major business markets. Marcum is a member of the Marcum Group, an organization providing a comprehensive range of professional services spanning accounting and advisory, technology solutions, wealth management, and executive and professional recruiting. The Marcum Group companies include Marcum LLPMarcum Technology LLCMarcum Search LLCMarcum Financial Services LLCMarcum Bernstein & Pinchuk LLPMarcumBuchanan Associates LLC; and Marcum Cronus Partners LLC.

Investor/Media Contacts

Amarantus
Russell Miller 
Director of Investor Relations
(650) 241 -3507 Ext 109

LHA
Don Markley , Senior Vice President
310.691.7100
dmarkley@lhai.com